Haematologica, Vol 92, Issue 10, 1435-1437 doi:10.3324/haematol.11122
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pigazzi, M.
Right arrow Articles by Basso, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pigazzi, M.
Right arrow Articles by Basso, G.

Acute Lymphoblastic Leukemia

cAMP response element binding protein (CREB) overexpression CREB has been described as critical for leukemia progression

Martina Pigazzi*, Emanuela Ricotti°, Giuseppe Germano#, Diego Faggian@, Maurizio Aricò^, Giuseppe Basso*,

* From the Department of Pediatrics, Laboratory of Pediatric Onco-Hematology, University of Padova, Padova, Italy
° Department of Pediatrics, University of Torino, Torino, Ital
# Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
@ Department of Laboratory Medicine, Azienda Ospedaliera di Padova, Padova, Italy
^ Department of Pediatric, Hematology-Oncology, Ospedale dei Bambini "G. Di Cristina", Palermo, Italy

Correspondence: Giuseppe Basso, MD, University of Padua, Department of Pediatrics, Laboratory of Pediatric Onco-Hematology, via Giustiniani 3, 35128 Padua, Italy. Phone: international +39.049.8211466. Fax: international +39.049.8211462. E-mail: giuseppe.basso{at}unipd.it

CREB has been described as critical for leukemia progress. We investigated CREB expression in ALL and AML pediatric patients. CREB protein was significantly high (p<0.001) at diagnosis but not during remission. This study underlines the role of CREB in leukemia and suggests new insights into the transformation process.




This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
A. Shukla, M. W. Bosenberg, M. B. MacPherson, K. J. Butnor, N. H. Heintz, H. I. Pass, M. Carbone, J. R. Testa, and B. T. Mossman
Activated cAMP Response Element Binding Protein Is Overexpressed in Human Mesotheliomas and Inhibits Apoptosis
Am. J. Pathol., November 1, 2009; 175(5): 2197 - 2206.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. M. Sakamoto and D. A. Frank
CREB in the Pathophysiology of Cancer: Implications for Targeting Transcription Factors for Cancer Therapy
Clin. Cancer Res., April 15, 2009; 15(8): 2583 - 2587.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Pigazzi, E. Manara, E. Baron, and G. Basso
miR-34b Targets Cyclic AMP-Responsive Element Binding Protein in Acute Myeloid Leukemia
Cancer Res., March 15, 2009; 69(6): 2471 - 2478.
[Abstract] [Full Text] [PDF]